MARKET WIRE NEWS
  1. Home
  2. Stock
  3. MLTX
  4. News
  5. Moonlake Positive Fda Meeting Spurs Momentum Ahead O
MLTX
Quote
Short
News
Articles
Message Board

MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission

Source: SeekingAlpha

2026-01-09 08:15:00 ET

Thesis

Read the full article on Seeking Alpha

For further details see:

MoonLake: Positive FDA Meeting Spurs Momentum Ahead Of BLA Submission
MoonLake Immunotherapeutics

NASDAQ: MLTX

MLTX Trading

0.79% G/L:

$17.255 Last:

279,190 Volume:

$17.14 Open:

mwn-link-x Ad 300

MLTX Latest News

February 25, 2026 06:00:42 am
Expected US Company Earnings on Wednesday, February 25th, 2026
February 25, 2026 04:31:02 am
Expected earnings - MoonLake Immunotherapeutics
February 24, 2026 08:03:55 am
MLTX Price Target Alert: $35.00. Issued by Oppenheimer
February 22, 2026 11:00:00 am
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results

MLTX Stock Data

$1,003,283,878
28,454,210
3.61%
24
N/A
Biotechnology & Life Sciences
Healthcare
https://www.moonlaketx.com
CH
Zug

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App